Profile: Nanomics Biosciences, Inc. offers a full suite of services ranging from experimental design expertise to an innovative tiered approach to data analysis. We help to identify active genes and proteins (biomarkers) from cellular interactions of engineered nanomaterials. We have also used the same services to assess the effectiveness and safety of pharmaceuticals, chemicals & other substances. We use high-throughput screening technologies to assess the effectiveness and safety of engineered nanomaterials. Nanotechnology is the pioneering field of manufacturing and developing materials on the scale of one billionth of a meter. These engineered nanomaterials are being used and developed for areas such as medical imaging, diagnostics & therapies, information technology & communications, building & construction, consumer products, and transportation. We use a proprietary process of tightly-controlled parameters lessening the process variability so that the biological responses can be observed. We prefer to use a systems biology approach. We have expertise in experimental designs for both drug discovery and preclinical development. We adhere to the current MIAME (Minimal Information About Microarray) guidelines. We can coordinate with a variety of primary cell culture and cell line investigations as well as investigations in several mammalian species. We can coordinate mRNA expression profiling using microarray platforms (e.g. affymetrix, agilent) or RT-PCR. We can also coordinate protein expression profiling using two-dimensional PAGE platforms or label-free protein quantification methods.
7 Products/Services (Click for related suppliers)
|•||Drug Discovery Systems Design||•||Drug Discovery Technologies||•||General Bioinformatics|
|•||MicroRNA Expression Profiling||•||New Drug Discovery||•||PCR Based Expression Profiling (Human)|
|•||Pre-Clinical Development Services|